When each ratio stops making sense

Two companies both trade at a price-to-earnings multiple of 6. In each case, that is the lowest multiple in their sector. One of them is a consumer business that has grown its earnings steadily for a decade. The other is a steel maker in the final quarter of a once-in-a-cycle pricing boom. A stock screener ranks the two side by side and labels them both "cheap." A buyer who trusts the screener will reach for both of them. And that buyer will be completely right about one, and completely wrong about the other. illustrative

The problem is not that the P/E has been calculated incorrectly. It has been calculated perfectly. The problem is that, for the steel maker, the ratio has quietly stopped meaning what the buyer thinks it means. A low multiple sitting on peak earnings is not a bargain. It is a warning. This module is about that exact moment, when a ratio goes dark. It keeps producing a number, but it has stopped answering the question you are actually asking. And it is about learning to see that darkness before you act on the number.

Every ratio is really a question, dressed up to look like an answer. ROCE asks how well a business turns its capital into operating profit. That is a superb question to ask of a manufacturer. It is a meaningless question to ask of a bank, whose deposits are its raw material rather than capital it has employed. EV/EBITDA asks what a company's cash operating earnings are worth, setting aside how it is financed. That is a sensible question for a cable company. It is an absurd question for a lender, because for a lender the interest is the business, not a financing item to be added back. Price-to-book is a solid anchor for a bank, and it is wildly misleading for an asset-light software firm that has almost no tangible assets on its books.

A ratio breaks in one of two ways. The first is that the sector disqualifies it. The business is built so differently that the ratio's underlying question simply does not apply. The second is that the situation disqualifies it. The company might be a cyclical at the top of its cycle. It might be in the middle of building a big new asset. It might be making a loss, or carrying goodwill from a recent merger, or reporting on a period that is not twelve months long because it changed its year-end. An investor who has memorised what each ratio means, but not where it stops meaning anything, will reach the wrong conclusion faster, and more confidently, than someone who never learned the ratio at all. This is the session that stops that from happening.

Start from a single ratio and watch it survive some contexts and die in others.

Two failure modes run through everything.

The sector breaks it. Every ratio quietly assumes something about how the business is shaped, and some sectors break that assumption outright. Take a lender. Its EBITDA is meaningless, because for a lender interest is core revenue, not a financing cost to be added back. Its ROCE has no clean capital-employed base to work from. Its interest coverage treats the cost of its own goods as if it were a burden. And leverage of ten-to-one is simply the business model, not a sign of distress. So for a lender you fall back on book value and return on equity instead. Take a life insurer. Its reported profit and its book value are both distorted by the way it has to set reserves, so the industry uses embedded value instead. Take an asset-light services firm. Its book value is tiny, so price-to-book comes out enormous and tells you nothing, and its return on equity is inflated by that same tiny denominator. Take a holding company. Its consolidated earnings double-count the subsidiaries it owns, so the right tool is the discount to net asset value, not the P/E.

The situation breaks it. Even in a sector where a ratio usually works fine, a particular moment in the company's life can disable it. A cyclical at the top of its cycle shows a low P/E, but that low P/E is sitting on inflated earnings, so it actually inverts. Here, a low multiple means expensive, not cheap. The same cyclical at the bottom of its cycle shows a high or even negative P/E, at exactly the point the stock is cheapest. A company part-way through a big capex project carries construction-in-progress that swells its capital employed while earning nothing yet, so its ROCE falls mechanically and understates the assets that are actually running. A loss-making company has no P/E at all, and a broken EV/EBITDA. A company fresh from a merger carries goodwill that inflates its book value and drags down its return ratios. And a company that changed its year-end reports a stub period of odd length, which makes every growth rate and every trailing ratio non-comparable.

The discipline is a two-step reflex. Before you read any ratio, ask two questions. What sector is this? And what situation is the company in? Then grey out, in your head, everything that just went dark.

Here is the same panel of six ratios, shown across four different contexts. A filled dot means the ratio still answers its question in that context. A struck-out dot means it has gone dark. Notice how few ratios survive for a lender and for a holding company, and notice that the ones which do survive are not the same from one to the next.

Two of these four do more than just disable a ratio. They invert the naive reading. For the cyclical at its peak, the earnings multiples do not merely weaken. They point the wrong way. So the entry that looks "cheapest" on the screen is actually the most dangerous one. For the holding company, almost the entire standard toolkit goes dark, and the one honest tool, the discount to net asset value, is one the screener never even computes. The lender and the insurer show the sector failure in its purest form. Ratios that are the backbone of manufacturing analysis simply do not apply to them, and importing those ratios anyway produces confident nonsense. The lesson here is not that these businesses cannot be analysed. It is that each one has its own valid set of instruments. The first skill is knowing which tools on the standard dashboard to ignore.

A composite specialty-sugar maker shows up on the screener with a P/E of 5, an ROCE of 24%, and an EV/EBITDA of 3.5. The whole screen is green. The naive read is obvious: outstanding returns, and trivially cheap. Now apply the two-step reflex. illustrative

First, what sector is this? Sugar is a hard cyclical. Its output and its selling prices swing around with cane pricing, with government policy, and with the harvest. Second, what situation is the company in? The trailing twelve months happen to have captured a policy-driven price spike, so realisations are near a cycle high right now. That single fact disarms the whole screen. The P/E of 5 is sitting on peak earnings. Normalise those realisations down to a mid-cycle level, and the "E" roughly halves. So the real multiple is closer to 10, and it is climbing as the cycle turns down. The 24% ROCE is a peak-cycle number too. Through the mid-cycle it might be more like 10% to 12%. The EV/EBITDA of 3.5 is the same illusion wearing a different costume.

What would change this conclusion? If you genuinely believed the higher selling prices were structural rather than cyclical, because of a durable policy shift or a permanent shortage of supply, then the ratios would regain their meaning, because in that case the "peak" is simply the new normal. Short of that, the right instruments are the through-cycle ones. Look at price-to-book against the company's own history. Look at mid-cycle margins. And look at whether the balance sheet can survive the next trough. It is the same green screen either way. But the conclusion is the opposite, and only the cycle context tells the two apart.

Pick a sector, and pick a situation. Every ratio that has stopped meaning anything greys out, with a one-line reason for why it went dark. A loss-making lender loses two overlapping sets of ratios at once: the ones its sector disqualifies, and the ones its situation disqualifies. That is exactly how these disqualifications stack up in the real world.

Knowing which ratios are valid narrows down your toolkit. It does not hand you a verdict. A price-to-book that survives for a lender still cannot tell you whether the book itself is honest, whether the loans behind it are sound or quietly going bad. A through-cycle P/E on a cyclical still depends on your own estimate of mid-cycle earnings, and that estimate is a judgement, not a fact. Embedded value for an insurer rests on actuarial assumptions that you did not set and cannot see. Ruling a ratio in only means that it is asking the right question of this particular business. The quality of the answer still depends on the integrity of the numbers going in, and that is the subject of Part Three.

There is also a humbler limit to keep in mind. This module teaches the common ways a ratio gets disqualified. It does not teach every one. A brand-new kind of business, a bespoke financing structure, or an odd accounting policy can disable a ratio in a way that no checklist could have anticipated. So the reflex matters more than any fixed list of cases. Always ask what the ratio is assuming, and then ask whether this business actually honours that assumption.

How it comes up. When a stock screens cheap for a reason the screener cannot see, an analyst tests whether management is leaning on the flattering ratio. The question sounds like this: "You've pointed to the low P/E and EV/EBITDA. But aren't those flattered by where we are in the cycle? What do mid-cycle returns look like?" The analyst is asking management to admit which ratios have gone dark.

A good answer, verbatim-style.

"You're right not to take the headline multiple at face value. Realisations this year are well above what we'd underwrite through the cycle. On mid-cycle pricing, EBITDA margin is closer to 15% than this year's 24%, and ROCE settles around 11–12%, not the 24% you see now. We manage the balance sheet for the trough, not the peak — net debt to mid-cycle EBITDA is under 2x. So we'd point you to book value and mid-cycle returns rather than the trailing P/E."

This is a good answer. Management names the distortion itself, supplies the actual mid-cycle numbers, and points you to the ratios that genuinely work for a cyclical.

An evasive answer, verbatim-style.

"We're the cheapest stock in the sector on almost every metric — P/E, EV/EBITDA, you name it. The market simply hasn't recognised the value yet. Demand is robust and we're very confident in the outlook. At these multiples the risk-reward is clearly attractive."

Look at what that answer is doing. It stacks up the cycle-inflated multiples as if they were durable. It appeals to "the market hasn't recognised it." And it does not give a single mid-cycle number. It is selling the exact ratio that has stopped making sense.

The follow-up nobody asks, and what its absence means. "What are your mid-cycle EBITDA margin and ROCE, and where does net debt sit against mid-cycle EBITDA, not peak EBITDA?" That question reframes every ratio onto through-cycle earnings, which is the only honest way to judge a cyclical, and it tests whether the balance sheet can survive the trough. Watch what happens when nobody asks it. If the room lets "cheapest in the sector" stand on peak numbers, that silence tells you one of two things. Either the mid-cycle figures are unflattering enough that not asking has become the kindness, or the analysts who would have normalised the cycle have already stopped covering the name. A cyclical being sold on its trailing multiple, on a call where nobody normalises it, is the precise setup this module exists to catch.

1. Trusting the screener's ranking across unlike businesses. A screen sorts a bank, a cyclical, and an asset-light firm all in the same P/E column, as if the number meant the same thing in each. It does not. The ranking is only valid within a set of genuinely comparable companies.

2. Reading a cyclical's low multiple as cheap. At the peak of the cycle, a low P/E and a low EV/EBITDA are sitting on inflated earnings, so they invert. Cheap-looking is actually expensive. The anchors that work through the cycle are book value and mid-cycle returns.

3. Applying manufacturing ratios to a lender. ROCE, EV/EBITDA, and interest coverage all break for a bank or an NBFC, where interest is the business and heavy leverage is the model. Importing those ratios produces confident, wrong conclusions.

4. Admiring an asset-light firm's ROE without checking the denominator. A 35% to 40% ROE on a near-zero equity base can be pure arithmetic, not excellence. What tells you which it is are the margins, the growth, and the cash conversion.

5. Reading mid-build ROCE as deterioration. Construction-in-progress in the denominator drags ROCE down while it earns nothing yet. Recompute the ratio without it, to see the returns on the assets that are actually running.

6. Forgetting the situation after checking the sector. A ratio can be right for the sector and still disabled by a one-off — a post-merger goodwill load, a changed year-end, a loss year. Both filters have to pass before you trust the number.